Nitisinone Menagen

Nitisinone Menagen
Product Description

Indicated for hereditary tyrosinemia type 1 

Menagen Pharmaceuticals

  • OM
  • 2024
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Biopharmaceutical company
Specifications
  • Details
    Nitisinone 2,5,10 MG (60 Cap/bottle)
  • Supplied from
    Oman

Menagen Pharmaceuticals

  • OM
  • 2024
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Biopharmaceutical company

More Products from Menagen Pharmaceuticals (4)

  • Darbegen

    Product Darbegen

    Indicated for Chronic Kidney Disease Anemia 
  • Ezirosy

    Product Ezirosy

    Treatment for Dyslipidemia 
  • Renagen

    Product Renagen

    Indicated for hyperphosphatemia 
  • Ryzneuta

    Product Ryzneuta

    Indicated for chemotherapy induced neutropenia